Related Blog Posts
Cardiomyopathy Patient Declares He Could Do A Triathlon After Adult Stem Cell Treatment
23 hours ago ago from Goodhealth-108.com: A weblog for persons who interested in good health and self health care information and resources.
Until eighteen months ago Jason Ludwick's life was dominated by what he could not do. He was in and out of hospital and living on a cocktail of expensive drugs to try and keep his failing heart functioning. Then, like hundreds of others he went to Thailand for adult stem cell therapy to get real help for heart disease. Jason Ludwick aged 34 from West Bloomfield, Michigan, counts himself a lucky man. Born with an atrial septal defect, by the ...
Related contentStem cell therapies for hearts inching closer to wide use
7 hours ago ago from The Mackney Warriors Blog
If you've just had your first heart attack, doctors may one day be able to reverse the damage done with stem cell therapy. An intravenous method of injecting stem cells into patients who had experienced heart attacks within the previous 10 days suggested that this method works to repair not just manage heart damage, a recent study found. Read more about it here http://www.cnn.com/2009/HEALTH/12/18/stem.cells.heart/index.html
Related contentStem Cells: Mending a broken heart?
18 hours ago ago from DoctorE
Harvard stem cell researcher Kenneth Chien speaks about a cardiac stem cell discovery that may be the first step on the path to regenerating healthy heart muscle.
Related contentRelated News
Celgene's Revlimid meets cancer study goal
8 hours ago ago from U.S. News
Celgene's Revlimid meets cancer study goal SUMMIT, N.J. (AP) -- Celgene Corp. said Friday data from a late-stage study show Revlimid significantly slowed the progression of multiple myeloma in patients following a type of stem cell treatment. The study is being conducted by the National Cancer Institute, which is part of the National Institutes of Health. It involves patients who have received autologous stem cell transplants, a procedure ...
Related contentScientist Is Crucial to the Bay Area’s Role in Stem Cell Research
22 hours ago ago from The New York Times
When Dr. Shinya Yamanaka arrived in the United States from Japan in 1993, he recalled recently, he was half a scientist, half a failed surgeon. A disaffected doctor with a newly minted Ph.D. in pharmacology, he had but one job offer, from the Gladstone Institutes, wedged into crowded laboratories by San Francisco General Hospital. Heidi Schumann for The New York Times He is the rock star of stem cell science, said Dr. Deepak ...
Related content
